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Arterial flow-mediated dilation (FMD) is an indirect measurement of endothelial nitric oxide (NO) release.1 
Impaired FMD represents systemic vascular endothelial dys-
function that is commonly associated with cardiovascular 
disease (CVD).2,3 In addition, the association of FMD with 
CVD is evidenced by its ability to predict future CVD events 
in population-based studies.4,5
Endothelial dysfunction, defined by impaired FMD, has 
been reported in patients with atrial fibrillation (AF).6,7 Also, 
abnormalities in NO signaling have been implicated in atrial 
ectopy near the pulmonary veins.8,9 These findings suggest a 
potential role for endothelial dysfunction in the development 
of AF. However, data from population-based studies to sup-
port this claim are lacking. The purpose of this study was to 
examine the association of brachial FMD with incident AF in 
the Multi-Ethnic Study of Atherosclerosis (MESA).
Materials and Methods
Materials and Methods are available in the online-only Data 
Supplement.
Results
Of the 3026 participants from the FMD ancillary study with 
available FMD measurements, 28 participants had a diagnosis 
of AF before enrolment in MESA. These cases were detected 
by Centers for Medicare & Medicaid Services linkage and 
were not detected in the baseline study ECG. Of those that 
remained, 3 participants with missing follow-up data and 59 
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participants missing either baseline characteristics or medica-
tion data were excluded. A total of 2936 study participants 
(mean age, 61±9.9 years; 50% women; 66% nonwhites) were 
included in the final analysis.
FMD was computed from the percentage difference 
(%FMD) in brachial artery diameter and maximum diameter 
during measured vasodilator responses. Baseline character-
istics stratified by sex-specific median %FMD are shown in 
Table 1. Participants with %FMD values below the median 
were more likely to be older, diabetic, and nonwhite and to 
have lower educational attainment and income compared with 
higher %FMD values. Persons with %FMD values below the 
median value were more likely to have increased values for 
systolic blood pressure and high-density lipoprotein choles-
terol, and lower values for total cholesterol than those with 
%FMD values above the median value. Higher rates of anti-
hypertensive medications, aspirin, lipid-lowering therapies, 
and left ventricular hypertrophy also were observed in peo-
ple with %FMD values below the median value.
A total of 137 (4.7%) participants developed AF during the 
study period. Median follow-up for study participants was 
8.5 years (interquartile range, 7.9–8.7). Unadjusted cumula-
tive incidence curves stratified by median %FMD are shown 
in the Figure. Participants with %FMD less than the median 
value (incidence rate per 1000 person-years, 7.3; 95% con-
fidence interval, 5.9–9.0) were more likely to develop AF 
compared with participants who had %FMD values greater 
than the median value (incidence rate per 1000 person-years, 
4.5; 95% confidence interval, 3.4–5.8; log-rank P=0.0043).
In a multivariable Cox proportional-hazards analy-
sis, each 1-SD increase in %FMD values (SD, 2.8%) was 
associated with less incident AF (Table 2). The association 
between FMD and AF remained significant after further 
adjustment of model 2 with amino-terminal pro-brain natri-
uretic peptide (hazard ratio, 0.83; 95% confidence interval, 
0.69–0.99). These results were consistent across subgroups 
of MESA participants stratified by age, sex, and race/ethnic-
ity (Table 2).
Discussion
In this analysis from MESA, lower brachial FMD values were 
associated with increased rates of AF. These findings suggest 
that endothelial dysfunction, as measured by brachial FMD, 
plays a role in the pathogenesis of AF.
To our knowledge, only 2 studies have examined the asso-
ciation of brachial FMD with AF. A study of chronic AF par-
ticipants showed that FMD measurements are significantly 
impaired compared with sinus rhythm controls.6 Another 
case–control study showed that participants with persistent 
AF have impaired FMD and that FMD improves after the 
restoration of sinus rhythm.7 However, both studies examined 
FMD among participants who already had AF. The current 
study examined FMD among participants without diagnosed 
AF and showed that lower FMD values are associated with 
an increased risk of AF development. In addition, participants 
with lower %FMD values were observed to have a higher inci-
dence of AF than those in the general population.10 Therefore, 
our results provide evidence that impaired FMD precedes the 
development of AF, suggesting a role for endothelial dysfunc-
tion in AF pathogenesis.
Endothelial cells regulate oxidative stress, vascular perme-
ability, platelet aggregation, thrombosis, and vascular tone 
by controlling the release of several vasoactive substances, 
including NO.11 The dysfunctional endothelium results in 
the downregulation of NO and the upregulation of adhesion 
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Age, mean (SD), y 64 (10) 58 (9.1) <0.0001
Male sex (%) 738 (50) 722 (49) 0.61
Race/ethnicity
  White (%) 440 (30) 561 (38) ...
  Black (%) 396 (27) 205 (14) ...
  Chinese- 
American (%)
263 (18) 326 (22) ...
  Hispanic (%) 371 (25) 374 (26) <0.0001
High school or 
less (%)
569 (39) 496 (34) 0.0060
Income <$20 000 (%) 407 (28) 351 (24) 0.020
Body mass index, 
mean (SD), kg/m2
28 (5.1) 28 (5.4) 0.44
Current or former 
smoker (%)
697 (47) 679 (46) 0.55




128 (20) 121 (19) <0.0001
Total cholesterol, 
mean (SD), mg/dL
193 (36) 196 (34) 0.048
HDL cholesterol, 
mean (SD), mg/dL
51 (14) 50 (14) 0.014
Antihypertensive 
medications (%)
570 (39) 427 (29) <0.0001
Statins (%) 222 (15) 185 (13) 0.052
Aspirin (%) 357 (24) 311 (21) 0.047
Lipid-lowering 
medications (%)
245 (17) 205 (14) 0.044
hs-CRP, mean (SD), 
mg/L
3.5 (5.3) 3.4 (5.7) 0.13
Left ventricular 
hypertrophy (%)
70 (4.8) 34 (2.3) 0.0003
FMD indicates flow-mediated dilation; HDL, high-density lipoprotein; and hs-
CRP, high-sensitivity C-reactive protein.
*Median %FMD values for male and female participants were 3.6% and 
4.2%, respectively.
†Statistical significance was tested for categorical variables using the χ2 
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molecules that promote increased levels of inflammation and 
oxidative stress. Recent evidence suggests that increased oxi-
dant generation by endothelial NADPH oxidase promotes 
the uncoupling of NO synthase and subsequent generation of 
reactive oxygen species and oxidative injury that leads to the 
electrophysiological remodeling observed in AF.8 In addition, 
exogenous NO has been shown to reduce spontaneous elec-
tric activity in cardiomyocytes isolated from the pulmonary 
vein, implicating NO as a regulator of AF arrhythmiogenesis.9 
Endothelial dysfunction also is associated with increased lev-
els of inflammation that result in atrial ectopy in discharging 
cells near the pulmonary veins.12,13 It is plausible that persons 
with endothelial dysfunction are more likely to have dys-
functional regulation of the aforementioned processes that 
increase their risk for AF. Therefore, FMD potentially is able 
to identify abnormal vascular biological profiles that precede 
AF development. 
Alternatively, several shared risk factors for AF, such as 
increasing age, diabetes mellitus, hypertension, and smok-
ing, have been associated with endothelial dysfunction.14–18 
Potentially, these conditions increase the level of vascular 
endothelial dysfunction and predispose individuals to AF. 
However, our results remained significant after adjustment 
for these risk factors, suggesting that the association between 
endothelial dysfunction and AF is not completely explained 
by shared risk factors.
Brachial FMD has been shown to independently predict 
incident CVD events among people who are free of CVD at 
baseline.5 Abnormal FMD values possibly identify individuals 
with subclinical atherosclerosis who are at-risk for CVD. In 
addition, as evidenced by our results, FMD potentially is able 
to identify persons who are at-risk for AF. However, further 
research is needed to examine the predictive ability of FMD 
for AF among at-risk populations before screening programs 
that use FMD are introduced.
Our results should be interpreted in the context of certain 
limitations. Paroxysmal cases of AF possibly were missed 
because of its time-dependent nature. Incident AF cases were 
ascertained from hospitalization discharge records and inpa-
tient Medicare claims data using International Classification 
of Disease codes, which possibly resulted in misclassifica-
tion. However, this method has been reported to have ade-
quate positive predictive value for AF case identification.19–21 
Brachial FMD measurements were obtained during the initial 
MESA visit and the association of FMD with AF may vary 
with repeat FMD measurements. The clinical significance 
of the FMD values (eg, increase per 1-SD, median) used in 
this study is unknown and those used were designed to dem-
onstrate exploratory associations (eg, lower FMD values are 
associated with increased AF risk). Future studies are needed 
to define clinically relevant values. Nonsignificant interac-
tions were observed by age, sex, and race/ethnicity but the 
current analysis potentially was underpowered to detect such 
differences. Furthermore, our results are limited regarding 
Figure. Cumulative incidence of atrial fibrillation by median per-
centage flow-mediated dilation (%FMD). Median %FMD values 
for male and female participants were 3.6% and 4.2%, respec-
tively. Kaplan–Meier estimates were significantly different (log-
rank P=0.0043). 
Table 2. Association of FMD With Atrial Fibrillation by Age, Sex, and Race/Ethnicity*
Events/No. at Risk
Model 1†
HR (95% CI) P Value
Model 2‡
HR (95% CI) P Value P Interaction§
All 137/2936 0.82 (0.69–0.98) 0.029 0.84 (0.70–0.99) 0.048 ...
Age, y
  ≤65 47/1898 0.68 (0.52–0.89) 0.0048 0.73 (0.56–0.95) 0.022 0.55
  >65 90/1038 0.79 (0.63–0.99) 0.037 0.81 (0.64–1.01) 0.065
Race
  White 70/1001 0.88 (0.70–1.1) 0.27 0.86 (0.68–1.1) 0.22 0.97
  Nonwhite 67/1935 0.77 (0.59–1.0) 0.054 0.83 (0.64–1.1) 0.19
Sex
  Male 85/1460 0.87 (0.69–1.1) 0.26 0.89 (0.70–1.1) 0.33 0.31
  Female 52/1476 0.77 (0.59–0.99) 0.048 0.77 (0.59–1.01) 0.062
CI indicates confidence interval; FMD, flow-mediated dilation; and HR, hazard ratio.
*HRs presented are for %FMD per 1-SD increase (SD, 2.8%). Subgroups were adjusted according to models 1 and 2 excluding the covariate of interest.
†Adjusted for age, sex, race/ethnicity, income, and education.
‡Adjusted for model 1 covariates plus smoking status, systolic blood pressure, diabetes mellitus, body mass index, total cholesterol, high-density lipoprotein 
cholesterol, aspirin, antihypertensive and lipid-lowering medications, high-sensitivity C-reactive protein, and left ventricular hypertrophy.
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generalizability to other populations because of the older age 
of participants with FMD values lower than the median value 
for study participants.
In conclusion, we have shown that brachial FMD values 
are inversely associated with incident AF in MESA. Our 
results suggest that endothelial dysfunction precedes the 
development of AF and may play an important role in the 
pathogenesis of this common arrhythmia. Further research is 
needed to confirm our findings and also to explore the clini-
cal use of FMD to identify those who are at-risk for develop-
ing AF.
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Endothelial dysfunction has been reported in patients with atrial fibrillation. However, the temporal association between impaired endothelial 
function and atrial fibrillation has not been examined. In this analysis from the Multi-Ethnic Study of Atherosclerosis, we have shown that 
impaired brachial artery flow-mediated dilation, an indirect marker of endothelial dysfunction, precedes the development of atrial fibrillation. 
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